Bausch Health Companies
BHC
$0.07 (-1.50%)
1D
1W
3M
1Y
5Y
ALL
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye Read More...Read Less
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 6 hours ago • BHC
Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United StatesZacks Investment Research • 1 day ago • BHC
New Strong Sell Stocks for May 13thBusiness Wire • 7 days ago • BHC
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular LensAccesswire • 8 days ago • BHC
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE RehospitalizationZacks Investment Research • 13 days ago • BHC
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock DownCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.